Effect of cholecystokinin receptor antagonist on pancreatic responses to exogenous gastrin and cholecystokinin and to meal stimuli
- PMID: 3345871
- DOI: 10.1016/0016-5085(88)90561-6
Effect of cholecystokinin receptor antagonist on pancreatic responses to exogenous gastrin and cholecystokinin and to meal stimuli
Abstract
Exocrine pancreatic response to food is believed to result from the interaction of neural and hormonal factors, but their contribution in the net postprandial secretion is unknown. Recent description of a highly specific and potent cholecystokinin (CCK)-receptor antagonist permitted the evaluation of the physiologic role of CCK in postprandial pancreatic secretion. In dogs with chronic pancreatic fistula, CCK antagonism caused little alteration in sham feeding- or urecholine-induced pancreatic protein secretion, but reduced by approximately 60% the pancreatic protein response to a gastrointestinal meal and virtually abolished the pancreatic responses to duodenal perfusion with amino acids or oleate and to exogenous CCK, but not to secretin or neurotensin. The pancreatic protein responses, particularly to lower doses of gastrin, were also reduced by CCK-receptor antagonist, but no changes in the responses to secretin or neurotensin were detected. Cholecystokinin antagonism also significantly reduced the pancreatic polypeptide responses to CCK, gastrin, and the gastrointestinal meal, possibly due to removal of the CCK-mediated release of pancreatic polypeptide. We conclude that CCK plays a crucial role in the mediation of the gastrointestinal phase, but not the cephalic phase, of pancreatic secretion.
Similar articles
-
Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.Scand J Gastroenterol. 1990 Jul;25(7):731-8. doi: 10.3109/00365529008997600. Scand J Gastroenterol. 1990. PMID: 2396088
-
Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.J Clin Invest. 1990 Mar;85(3):640-6. doi: 10.1172/JCI114486. J Clin Invest. 1990. PMID: 2312719 Free PMC article.
-
Role of cholecystokinin in the control of gastric emptying and secretory response to a fatty meal in normal subjects and duodenal ulcer patients.Scand J Gastroenterol. 1994 Jul;29(7):583-90. doi: 10.3109/00365529409092476. Scand J Gastroenterol. 1994. PMID: 7939393 Clinical Trial.
-
Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.J Physiol Pharmacol. 1994 Dec;45(4 Suppl 1):3-66. J Physiol Pharmacol. 1994. PMID: 7787215 Review.
-
Effects of CCK on pancreatic function and morphology.Ann N Y Acad Sci. 1994 Mar 23;713:180-98. doi: 10.1111/j.1749-6632.1994.tb44065.x. Ann N Y Acad Sci. 1994. PMID: 8185159 Review.
Cited by
-
Effect of the cholecystokinin-receptor antagonist lorglumide on pancreatic enzyme secretion stimulated by bombesin, food, and caerulein, giving similar plasma cholecystokinin concentrations in the dog.Gut. 1991 Feb;32(2):215-9. doi: 10.1136/gut.32.2.215. Gut. 1991. PMID: 1864545 Free PMC article.
-
Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas.J Physiol. 1989 Apr;411:419-35. doi: 10.1113/jphysiol.1989.sp017581. J Physiol. 1989. PMID: 2614728 Free PMC article.
-
CCK receptor antagonism by loxiglumide and gall bladder contractions in response to cholecystokinin, sham feeding and ordinary feeding in man.Gut. 1989 Aug;30(8):1136-42. doi: 10.1136/gut.30.8.1136. Gut. 1989. PMID: 2767511 Free PMC article.
-
Duration of anti-cholecystokinin (CCK) action on the rat exocrine pancreas of new CCK receptor antagonist FK480 administered orally.J Gastroenterol. 1996 Apr;31(2):249-53. doi: 10.1007/BF02389525. J Gastroenterol. 1996. PMID: 8680546
-
Physiological role of cholecystokinin on postprandial insulin secretion and gastric meal emptying in man. Studies with the cholecystokinin receptor antagonist loxiglumide.Diabetologia. 1991 Oct;34(10):721-6. doi: 10.1007/BF00401517. Diabetologia. 1991. PMID: 1959704 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources